Sign in

CIK 0001816736

  • Large accelerated filer

Disc Medicine, Inc.

Sign in to watch
Ticker
IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
851612845
Phone
+1 617-674-9274
Business address
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Former names
Gemini Therapeutics, Inc. /DE, FS Development Corp.
  1. 4 Exercise or conversion Chief Financial Officer acquired 2,500 shares (option exercise)
  2. 4 Planned sale Chief Financial Officer sold 1,000 shares at $52.99 ($52,990)
  3. 4 Exercise or conversion Chief Medical Officer acquired 3,000 shares (option exercise)
  4. 4 Open-market sale Director sold 72,931 shares at $52.40 ($3,821,584)
  5. 3/A Insider 3/A
  6. 4 Open-market sale 10% owner sold 359,000 shares at an average $52.49 ($18,845,200)
  7. 4 Planned sale Chief Medical Officer sold 7,672 shares at an average $52.95 ($406,235)
  8. 4 Planned sale Chief Medical Officer sold 8,269 shares at an average $49.83 ($412,064)
  9. 4 Planned sale Chief Financial Officer sold 4,521 shares at an average $49.91 ($225,633)
  10. 4 Planned sale Chief Innovation Officer sold 14,524 shares at an average $47.03 ($683,082)
  11. 4 Planned sale Chief Financial Officer sold 10,072 shares at an average $49.95 ($503,114)
  12. 4 Planned sale Chief Medical Officer sold 4,384 shares at an average $49.98 ($219,114)
  13. 4 Open-market sale 10% owner sold 1,250,000 shares at $46.10 ($57,625,000)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 15 · 283 filings